• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经紊乱和疾病中的罕见海洋生物活性化合物:血脑屏障是障碍还是靶点?

The Rare Marine Bioactive Compounds in Neurological Disorders and Diseases: Is the Blood-Brain Barrier an Obstacle or a Target?

机构信息

Department of Marine Bio-Pharmacology, College of Food Science and Technology, Shanghai Ocean University, Shanghai 201306, China.

Innovation Center, Shanghai BociMed Pharmaceutical Co., Ltd., Shanghai 201203, China.

出版信息

Mar Drugs. 2023 Jul 18;21(7):406. doi: 10.3390/md21070406.

DOI:10.3390/md21070406
PMID:37504937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10381592/
Abstract

The blood-brain barrier (BBB) is a dynamic barrier separating neurocytes and brain tissues from blood that is extremely sealed and strictly regulated by transporters such as aquaporin-4 (AQP-4), glucose transporter (GLUT), and specialized tight junctional complexes (TJCs) including tight junctions (TJs), adherens junctions (AJs), and Zonulae occludens (ZOs). With specifically selective transcellular and paracellular permeability, the BBB maintains a homeostatic microenvironment to protect the central nervous system (CNS). In recent years, increasing attention has been paied to the importance of BBB disruption and dysfunction in the pathology of neurological disorders and diseases, such as Alzheimer's diseases (AD), Parkinson diseases (PD), stroke and cerebral edema. However, the further research on how the integral structure and function of BBB are altered under the physiological or pathological conditions is still needed. Focusing on the ultrastructural features of the BBB and combining the latest research on associated proteins and transporters, physiological regulation and pathological change of the BBB were elucidated. By summarizing the protective effects of known bioactive compounds derived from marine life on the BBB, this review aims to highlight the BBB as a key to the treatment of several major neurological diseases instead of a normally described obstacle to drug absorption and transport. Overall, the BBB's morphological characteristics and physiological function and their regulation provide the theoretical basis for the study on the BBB and inspire the diagnosis of and therapy for neurological diseases.

摘要

血脑屏障(BBB)是一种将神经细胞和脑组织与血液分隔开来的动态屏障,其具有极高的封闭性,并受到水通道蛋白-4(AQP-4)、葡萄糖转运蛋白(GLUT)和专门的紧密连接复合体(TJCs)等转运体的严格调节,这些 TJCs 包括紧密连接(TJs)、黏着连接(AJs)和封闭小带(ZOs)。BBB 具有特定的细胞间和旁细胞通透性,可维持有助于保护中枢神经系统(CNS)的稳态微环境。近年来,人们越来越关注 BBB 破坏和功能障碍在神经病变和疾病(如阿尔茨海默病(AD)、帕金森病(PD)、中风和脑水肿)中的病理作用。然而,仍需要进一步研究在生理或病理条件下,BBB 的整体结构和功能如何发生改变。本文重点介绍 BBB 的超微结构特征,并结合与 BBB 相关的蛋白质和转运体的最新研究,阐明了 BBB 的生理调节和病理变化。通过总结已知海洋生物来源的生物活性化合物对 BBB 的保护作用,本文旨在强调 BBB 是治疗几种主要神经疾病的关键,而不是通常描述的药物吸收和转运障碍。总之,BBB 的形态特征、生理功能及其调节为 BBB 的研究提供了理论基础,并为神经疾病的诊断和治疗提供了启示。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ae/10381592/28ad7084d4d5/marinedrugs-21-00406-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ae/10381592/697b5036b870/marinedrugs-21-00406-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ae/10381592/044e57c566d1/marinedrugs-21-00406-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ae/10381592/2ff061aaaca7/marinedrugs-21-00406-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ae/10381592/3a40e0f58292/marinedrugs-21-00406-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ae/10381592/a7ae351a3758/marinedrugs-21-00406-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ae/10381592/d5e57e980a8b/marinedrugs-21-00406-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ae/10381592/28ad7084d4d5/marinedrugs-21-00406-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ae/10381592/697b5036b870/marinedrugs-21-00406-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ae/10381592/044e57c566d1/marinedrugs-21-00406-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ae/10381592/2ff061aaaca7/marinedrugs-21-00406-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ae/10381592/3a40e0f58292/marinedrugs-21-00406-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ae/10381592/a7ae351a3758/marinedrugs-21-00406-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ae/10381592/d5e57e980a8b/marinedrugs-21-00406-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1ae/10381592/28ad7084d4d5/marinedrugs-21-00406-g007.jpg

相似文献

1
The Rare Marine Bioactive Compounds in Neurological Disorders and Diseases: Is the Blood-Brain Barrier an Obstacle or a Target?神经紊乱和疾病中的罕见海洋生物活性化合物:血脑屏障是障碍还是靶点?
Mar Drugs. 2023 Jul 18;21(7):406. doi: 10.3390/md21070406.
2
Factors influencing the blood-brain barrier permeability.影响血脑屏障通透性的因素。
Brain Res. 2022 Aug 1;1788:147937. doi: 10.1016/j.brainres.2022.147937. Epub 2022 May 11.
3
Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection.缺血性脑卒中的血脑屏障功能障碍:针对紧密连接和转运体的血管保护作用。
Am J Physiol Cell Physiol. 2018 Sep 1;315(3):C343-C356. doi: 10.1152/ajpcell.00095.2018. Epub 2018 Jun 27.
4
miR-27a-3p regulates expression of intercellular junctions at the brain endothelium and controls the endothelial barrier permeability.miR-27a-3p 调节脑内皮细胞的细胞间连接表达,并控制内皮屏障通透性。
PLoS One. 2022 Jan 13;17(1):e0262152. doi: 10.1371/journal.pone.0262152. eCollection 2022.
5
Dysregulation of Ion Channels and Transporters and Blood-Brain Barrier Dysfunction in Alzheimer's Disease and Vascular Dementia.阿尔茨海默病和血管性痴呆中离子通道和转运体的失调及血脑屏障功能障碍。
Aging Dis. 2024 Aug 1;15(4):1748-1770. doi: 10.14336/AD.2023.1201.
6
The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction.血脑屏障和血脑脊液屏障:功能和功能障碍。
Semin Immunopathol. 2009 Nov;31(4):497-511. doi: 10.1007/s00281-009-0177-0. Epub 2009 Sep 25.
7
The dynamic blood-brain barrier.动态血脑屏障。
FEBS J. 2015 Nov;282(21):4067-79. doi: 10.1111/febs.13412. Epub 2015 Sep 8.
8
The blood-brain and gut-vascular barriers: from the perspective of claudins.血脑屏障和肠血管屏障:从紧密连接蛋白的角度看。
Tissue Barriers. 2021 Jul 3;9(3):1926190. doi: 10.1080/21688370.2021.1926190. Epub 2021 Jun 21.
9
Hypoxic Stress and Inflammatory Pain Disrupt Blood-Brain Barrier Tight Junctions: Implications for Drug Delivery to the Central Nervous System.缺氧应激和炎症性疼痛破坏血脑屏障紧密连接:对药物递送至中枢神经系统的影响。
AAPS J. 2017 Jul;19(4):910-920. doi: 10.1208/s12248-017-0076-6. Epub 2017 Mar 28.
10
Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier.血脑屏障中紧密连接的分子生理学与病理生理学
Trends Neurosci. 2001 Dec;24(12):719-25. doi: 10.1016/s0166-2236(00)02004-x.

引用本文的文献

1
Marine Derived Strategies Against Neurodegeneration.对抗神经退行性变的海洋衍生策略。
Mar Drugs. 2025 Jul 31;23(8):315. doi: 10.3390/md23080315.
2
TRPML1 acts as a predisposing factor in lymphedema development by regulating the subcellular localization of aquaporin-3, -5.瞬时受体电位黏蛋白1通过调节水通道蛋白3、5的亚细胞定位,在淋巴水肿发展过程中作为一个易感因素发挥作用。
PLoS One. 2024 Dec 5;19(12):e0310653. doi: 10.1371/journal.pone.0310653. eCollection 2024.
3
Protection of Tight Junctional Complexes between hCMEC/D3 Cells by Deep-Sea Fibrinolytic Compound FGFC1.

本文引用的文献

1
In vivo methods for imaging blood-brain barrier function and dysfunction.在体方法用于成像血脑屏障的功能和障碍。
Eur J Nucl Med Mol Imaging. 2023 Mar;50(4):1051-1083. doi: 10.1007/s00259-022-05997-1. Epub 2022 Nov 28.
2
Alzheimer's Disease: Treatment Strategies and Their Limitations.阿尔茨海默病:治疗策略及其局限性。
Int J Mol Sci. 2022 Nov 12;23(22):13954. doi: 10.3390/ijms232213954.
3
Marine Sources of DHA-Rich Phospholipids with Anti-Alzheimer Effect.富含 DHA 的磷脂的海洋来源及其抗老年痴呆作用。
深海纤维蛋白溶解复合物 FGFC1 对 hCMEC/D3 细胞紧密连接复合体的保护作用。
Mar Drugs. 2024 Jul 26;22(8):341. doi: 10.3390/md22080341.
4
Navigating neurological disorders: harnessing the power of natural compounds for innovative therapeutic breakthroughs.应对神经系统疾病:利用天然化合物的力量实现创新性治疗突破。
EXCLI J. 2024 Apr 23;23:534-569. doi: 10.17179/excli2024-7051. eCollection 2024.
5
Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives.用于胶质母细胞瘤中高效药物递送和耐药性的纳米颗粒:新视角。
CNS Neurosci Ther. 2024 May;30(5):e14715. doi: 10.1111/cns.14715.
6
Exploring Next-Generation Therapeutics: Morphic Mixtures and Specified Salts for the Treatment of Mental Disorders and CNS Modulation.探索下一代疗法:用于治疗精神障碍和中枢神经系统调节的形态混合物及特定盐类
ACS Med Chem Lett. 2023 Aug 22;14(9):1159-1161. doi: 10.1021/acsmedchemlett.3c00358. eCollection 2023 Sep 14.
Mar Drugs. 2022 Oct 25;20(11):662. doi: 10.3390/md20110662.
4
The barrier and interface mechanisms of the brain barrier, and brain drug delivery.脑屏障和界面机制,以及脑内药物递送。
Brain Res Bull. 2022 Nov;190:69-83. doi: 10.1016/j.brainresbull.2022.09.017. Epub 2022 Sep 23.
5
Transport Mechanisms at the Blood-Brain Barrier and in Cellular Compartments of the Neurovascular Unit: Focus on CNS Delivery of Small Molecule Drugs.血脑屏障及神经血管单元细胞区室的转运机制:聚焦小分子药物的中枢神经系统递送
Pharmaceutics. 2022 Jul 20;14(7):1501. doi: 10.3390/pharmaceutics14071501.
6
Progress in Isoindolone Alkaloid Derivatives from Marine Microorganism: Pharmacology, Preparation, and Mechanism.海洋微生物中异吲哚啉生物碱衍生物的研究进展:药理学、制备与作用机制。
Mar Drugs. 2022 Jun 20;20(6):405. doi: 10.3390/md20060405.
7
Antibody-based leukocyte label for two-photon brain imaging in mice.用于小鼠双光子脑成像的基于抗体的白细胞标记物。
Neurophotonics. 2022 Jul;9(3):031917. doi: 10.1117/1.NPh.9.3.031917. Epub 2022 May 24.
8
Blood-brain barrier leakage in Alzheimer's disease: From discovery to clinical relevance.阿尔茨海默病中的血脑屏障渗漏:从发现到临床相关性。
Pharmacol Ther. 2022 Jun;234:108119. doi: 10.1016/j.pharmthera.2022.108119. Epub 2022 Jan 30.
9
Marine Organisms as Alkaloid Biosynthesizers of Potential Anti-Alzheimer Agents.海洋生物作为潜在抗老年痴呆症药物的生物碱生物合成体。
Mar Drugs. 2022 Jan 15;20(1):75. doi: 10.3390/md20010075.
10
Blood-Brain Barrier Dysfunction in CNS Disorders and Putative Therapeutic Targets: An Overview.中枢神经系统疾病中的血脑屏障功能障碍及潜在治疗靶点:综述
Pharmaceutics. 2021 Oct 26;13(11):1779. doi: 10.3390/pharmaceutics13111779.